Start Date
May 25, 2023
Primary Completion Date
November 30, 2024
Study Completion Date
May 30, 2025
OnabotulinumtoxinA Standard Dose
Active comparator group will be treated for full upper face wrinkles with standard recommended doing of onabotulinumtoxinA
OnabotulinumtoxinA Half Standard Dose
Experimental group will be treated for full upper face wrinkles with half of the standard recommended doing of onabotulinumtoxinA
Lead Sponsor
Northwell Health
OTHER